How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Buy
61
OMCL Quote, Financials, Valuation and Earnings
Last price:
$49.00
Seasonality move
:
0.16%
Day range:
$48.55 - $50.70
52-week range:
$22.66 - $55.00
Dividend yield:
0%
P/E ratio:
117.17x
P/S ratio:
1.98x
P/B ratio:
1.84x
Volume:
197.2K
Avg. volume:
521K
1-year change:
12.65%
Market cap:
$2.2B
Revenue:
$1.1B
EPS (TTM):
$0.43
Analysts' Opinion
-
Consensus RatingOmnicell, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $55.00, Omnicell, Inc. has an estimated upside of 10.09% from its current price of $49.96.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $50.00 representing 100% downside risk from its current price of $49.96.
Fair Value
-
According to the consensus of 7 analysts, Omnicell, Inc. has 10.09% upside to fair value with a price target of $55.00 per share.
OMCL vs. S&P 500
-
Over the past 5 trading days, Omnicell, Inc. has overperformed the S&P 500 by 0.88% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Omnicell, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Omnicell, Inc. has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Omnicell, Inc. reported revenues of $310.6M.
Earnings Growth
-
Omnicell, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Omnicell, Inc. reported earnings per share of $0.12.
Enterprise value:
2.2B
EV / Invested capital:
--
Price / LTM sales:
1.98x
EV / EBIT:
120.11x
EV / Revenue:
1.89x
PEG ratio (5yr expected):
-3.94x
EV / Free cash flow:
23.72x
Price / Operating cash flow:
24.82x
Enterprise value / EBITDA:
21.06x
Gross Profit (TTM):
$516M
Return On Assets:
0.93%
Net Income Margin (TTM):
1.69%
Return On Equity:
1.6%
Return On Invested Capital:
1.22%
Operating Margin:
2.65%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.2B | $1.1B | $1.2B | $282.4M | $310.6M | |
| Gross Profit | $520.7M | $441M | $516M | $122.9M | $134.5M | |
| Operating Income | -$19.1M | -$21.6M | $18.5M | $7.2M | $8.2M | |
| EBITDA | $77.3M | $141.5M | $105.6M | $28.7M | $29.6M | |
| Diluted EPS | -$0.77 | -$0.39 | $0.43 | $0.19 | $0.12 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $888.7M | $849.1M | $913.8M | $1B | $643.2M | |
| Total Assets | $2.1B | $2.2B | $2.2B | $2.3B | $1.9B | |
| Current Liabilities | $338.7M | $376.7M | $369.4M | $961.5M | $456.6M | |
| Total Liabilities | $940.1M | $1B | $1B | $1.1B | $727.7M | |
| Total Equity | $1.1B | $1.1B | $1.2B | $1.2B | $1.2B | |
| Total Debt | $523.3M | $607.7M | $601.7M | $603.5M | $194.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $224.8M | $169.8M | $153.3M | $22.8M | $28.3M | |
| Cash From Investing | -$59.9M | -$51.6M | -$59.5M | -$13.3M | -$14.3M | |
| Cash From Financing | $13.9M | $12M | -$461.8M | $3.6M | -$220M | |
| Free Cash Flow | $165M | $118.2M | $93.8M | $9.4M | $14M | |
OMCL
Sector
Market Cap
$2.2B
$25.9M
Price % of 52-Week High
90.84%
51.6%
Dividend Yield
0%
0%
Shareholder Yield
8.69%
-1.66%
1-Year Price Total Return
12.65%
-18.99%
Beta (5-Year)
0.773
0.485
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$50.37
200-day SMA
Buy
Level
$33.81
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$49.14
Relative Strength Index (RSI14)
Buy
Level
55.47
ADX Line
Neutral
Level
0
Williams %R
Neutral
Level
-62.2069
50-day SMA
Buy
Level
$43.75
MACD (12, 26)
Buy
Level
9.43
25-day Aroon Oscillator
Buy
Level
28
On Balance Volume
Neutral
Level
--
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.3217)
Buy
CA Score
(Annual)
Level (0.0196)
Buy
Beneish M-Score
(Annual)
Level (-2.7493)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.8782)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Fort Worth, TX.
Stock Forecast FAQ
In the current month, OMCL has received 5 Buy ratings 2 Hold ratings, and 0 Sell ratings. The OMCL average analyst price target in the past 3 months is $55.00.
-
Where Will Omnicell, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Omnicell, Inc. share price will rise to $55.00 per share over the next 12 months.
-
What Do Analysts Say About Omnicell, Inc.?
Analysts are divided on their view about Omnicell, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Omnicell, Inc. is a Sell and believe this share price will drop from its current level to $50.00.
-
What Is Omnicell, Inc.'s Price Target?
The price target for Omnicell, Inc. over the next 1-year time period is forecast to be $55.00 according to 7 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is OMCL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Omnicell, Inc. is a Buy. 5 of 7 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of OMCL?
You can purchase shares of Omnicell, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Omnicell, Inc. shares.
-
What Is The Omnicell, Inc. Share Price Today?
Omnicell, Inc. was last trading at $49.00 per share. This represents the most recent stock quote for Omnicell, Inc.. Yesterday, Omnicell, Inc. closed at $49.96 per share.
-
How To Buy Omnicell, Inc. Stock Online?
In order to purchase Omnicell, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get OMCL Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
OMCL
Sector
P/E ratio
117.17x
23.82x
PEG ratio
-3.94x
-0.01x
P/B ratio
1.84x
1.83x
Price / LTM sales
1.98x
1.56x
Growth Metrics
OMCL
Sector
Revenue growth
9.99%
4.18%
Earnings growth
-35.99%
9.66%
Revenue (5-year growth)
4.4%
6.28%
Earnings forecast
$0.50
-$0.18
Profitability
OMCL
Sector
Profitability FY 2024
$475.5M
$3.1M
Return on invested capital
1.22%
-32.89%
Return on assets
0.93%
-29.56%
Return on equity
1.6%
-38.66%
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Feb
5
Estimated Next Earnings Date
Jan
29
Balance Sheet
OMCL
Sector
Total cash
$225.5M
$25.2M
Short term investments
$12.5M
$25.1M
Total assets
$2.1B
$73M
Long term debt
$194.9M
$3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 42x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 42x
Alerts
Buy
72
BNAI alert for Jan 29
Brand Engagement Network, Inc. [BNAI] is up 20.87% over the past day.
Sell
44
SANM alert for Jan 28
Sanmina Corp. [SANM] is up 6.61% over the past day.
Buy
56
CVNA alert for Jan 29
Carvana Co. [CVNA] is down 14.79% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
